| - GRCh37:
- Chr19:18989798
- GRCh38:
- Chr19:18878989
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006843
- GRCh38:
- Chr19:18896034
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006690
- GRCh38:
- Chr19:18895881
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990104
- GRCh38:
- Chr19:18879295
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006626
- GRCh38:
- Chr19:18895817
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990043
- GRCh38:
- Chr19:18879234
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006687
- GRCh38:
- Chr19:18895878
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004388
- GRCh38:
- Chr19:18893579
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994968
- GRCh38:
- Chr19:18884159
| GDF1, CERS1 | R173H, R75H | Progressive myoclonic epilepsy type 8 | Uncertain significance (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006684
- GRCh38:
- Chr19:18895875
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006845
- GRCh38:
- Chr19:18896036
| GDF1, CERS1 | P13T | Progressive myoclonic epilepsy type 8 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991168
- GRCh38:
- Chr19:18880359
| GDF1, CERS1 | I125V, I208V, I223V | Progressive myoclonic epilepsy type 8 | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994900
- GRCh38:
- Chr19:18884091
| GDF1, CERS1 | F196I, F98I | Progressive myoclonic epilepsy type 8 | Uncertain significance (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18981432
- GRCh38:
- Chr19:18870623
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989765
- GRCh38:
- Chr19:18878956
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Feb 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990200
- GRCh38:
- Chr19:18879391
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004404
- GRCh38:
- Chr19:18893595
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991201
- GRCh38:
- Chr19:18880392
| CERS1, GDF1 | S212G, S114G | Progressive myoclonic epilepsy type 8 | Uncertain significance (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991252
- GRCh38:
- Chr19:18880443
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990039
- GRCh38:
- Chr19:18879230
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990110
- GRCh38:
- Chr19:18879301
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991254
- GRCh38:
- Chr19:18880445
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006769
- GRCh38:
- Chr19:18895960
| CERS1, GDF1 | T38K | Progressive myoclonic epilepsy type 8 | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006867
- GRCh38:
- Chr19:18896058
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995066
- GRCh38:
- Chr19:18884257
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006780
- GRCh38:
- Chr19:18895971
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994885
- GRCh38:
- Chr19:18884076
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991247
- GRCh38:
- Chr19:18880438
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004327
- GRCh38:
- Chr19:18893518
| CERS1, GDF1 | A103T, A5T | Progressive myoclonic epilepsy type 8 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006734
- GRCh38:
- Chr19:18895925
| CERS1, GDF1 | A50S | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006648
- GRCh38:
- Chr19:18895839
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990215
- GRCh38:
- Chr19:18879406
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990201
- GRCh38:
- Chr19:18879392
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006801
- GRCh38:
- Chr19:18895992
| CERS1, GDF1 | W27C | Progressive myoclonic epilepsy type 8 | Uncertain significance (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989771
- GRCh38:
- Chr19:18878962
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990145
- GRCh38:
- Chr19:18879336
| GDF1, CERS1 | H171Y, H254Y, H269Y | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006734
- GRCh38:
- Chr19:18895925
| CERS1, GDF1 | A50P | Progressive myoclonic epilepsy type 8 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006865
- GRCh38:
- Chr19:18896056
| CERS1, GDF1 | P6R | Progressive myoclonic epilepsy type 8 | Uncertain significance (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994937
- GRCh38:
- Chr19:18884128
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995093
- GRCh38:
- Chr19:18884284
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jun 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994882
- GRCh38:
- Chr19:18884073
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18981444
- GRCh38:
- Chr19:18870635
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Sep 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991259
- GRCh38:
- Chr19:18880450
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Dec 7, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006726
- GRCh38:
- Chr19:18895917
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Nov 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006711
- GRCh38:
- Chr19:18895902
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994881
- GRCh38:
- Chr19:18884072
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Nov 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18981436
- GRCh38:
- Chr19:18870627
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991118
- GRCh38:
- Chr19:18880309
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jul 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989759
- GRCh38:
- Chr19:18878950
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006816
- GRCh38:
- Chr19:18896007
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Apr 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990030
- GRCh38:
- Chr19:18879221
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18994928
- GRCh38:
- Chr19:18884119
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990170
- GRCh38:
- Chr19:18879361
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004340
- GRCh38:
- Chr19:18893531
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990182
- GRCh38:
- Chr19:18879373
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Dec 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991259
- GRCh38:
- Chr19:18880450
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989720
- GRCh38:
- Chr19:18878911
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006702
- GRCh38:
- Chr19:18895893
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Nov 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995066
- GRCh38:
- Chr19:18884257
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991103
- GRCh38:
- Chr19:18880294
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Apr 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006873
- GRCh38:
- Chr19:18896064
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Feb 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989721
- GRCh38:
- Chr19:18878912
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004247
- GRCh38:
- Chr19:18893438
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004265
- GRCh38:
- Chr19:18893456
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989741
- GRCh38:
- Chr19:18878932
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18980021
- GRCh38:
- Chr19:18869212
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989771
- GRCh38:
- Chr19:18878962
| GDF1, CERS1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989804
- GRCh38:
- Chr19:18878995
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990152
- GRCh38:
- Chr19:18879343
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990134
- GRCh38:
- Chr19:18879325
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004232
- GRCh38:
- Chr19:18893423
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004218
- GRCh38:
- Chr19:18893409
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Dec 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989750
- GRCh38:
- Chr19:18878941
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990170
- GRCh38:
- Chr19:18879361
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990160
- GRCh38:
- Chr19:18879351
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Apr 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006853-19006864
- GRCh38:
- Chr19:18896044-18896055
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004327
- GRCh38:
- Chr19:18893518
| CERS1, GDF1 | A5S, A103S | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004371
- GRCh38:
- Chr19:18893562
| CERS1, GDF1 | R88Q | Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004285
- GRCh38:
- Chr19:18893476
| GDF1, CERS1 | A19S, A117S | Inborn genetic diseases, Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:19004284
- GRCh38:
- Chr19:18893475
| CERS1, GDF1 | A117V, A19V | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006800
- GRCh38:
- Chr19:18895991
| CERS1, GDF1 | G28S | Progressive myoclonic epilepsy type 8 | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006724
- GRCh38:
- Chr19:18895915
| CERS1, GDF1 | A53V | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991198
- GRCh38:
- Chr19:18880389
| CERS1, GDF1 | D198N, D115N, D213N | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989854
- GRCh38:
- Chr19:18879045
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006724
- GRCh38:
- Chr19:18895915
| CERS1, GDF1 | A53G | Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006671
- GRCh38:
- Chr19:18895862
| CERS1, GDF1 | T71A | Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991110
- GRCh38:
- Chr19:18880301
| GDF1, CERS1 | L144S, L227S, L242S | Progressive myoclonic epilepsy type 8 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990133
- GRCh38:
- Chr19:18879324
| GDF1, CERS1 | R175C, R258C, R273C | Progressive myoclonic epilepsy type 8 | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004329
- GRCh38:
- Chr19:18893520
| GDF1, CERS1 | S4N, S102N | Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18991137
- GRCh38:
- Chr19:18880328
| CERS1, GDF1 | H135R, H233R, H218R | Progressive myoclonic epilepsy type 8 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004372
- GRCh38:
- Chr19:18893563
| CERS1, GDF1 | R88W | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995046
- GRCh38:
- Chr19:18884237
| CERS1, GDF1 | D147G, D49G | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995082
- GRCh38:
- Chr19:18884273
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19006814
- GRCh38:
- Chr19:18896005
| CERS1, GDF1 | V23A | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989740
- GRCh38:
- Chr19:18878931
| CERS1, GDF1 | E322Q, E239Q, E337Q | Progressive myoclonic epilepsy type 8 | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18995095-18995096
- GRCh38:
- Chr19:18884286-18884287
| CERS1, GDF1 | | Progressive myoclonic epilepsy type 8 | Likely benign (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18990115
- GRCh38:
- Chr19:18879306
| CERS1, GDF1 | P181T, P279T, P264T | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18893725-19312528
| ARMC6, BORCS8, CERS1, COMP, COPE, DDX49, GDF1, HOMER3, MEF2B, NR2C2AP, RFXANK, SLC25A42, SUGP2, TMEM161A, UPF1 | | Progressive myoclonic epilepsy type 8 | Uncertain significance (Mar 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:18989775
- GRCh38:
- Chr19:18878966
| CERS1, GDF1 | T227I, T325I, T310I | Progressive myoclonic epilepsy type 8 | Uncertain significance (Aug 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:19004315
- GRCh38:
- Chr19:18893506
| CERS1, GDF1 | L107V, L9V | Progressive myoclonic epilepsy type 8 | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |